COVID-19: Biggest AstraZeneca jab maker unlikely to resume major exports 'for at least three months' as it keeps doses for India surge

The world's biggest maker of the AstraZeneca vaccine is unlikely to resume major exports until at least October as it prioritises doses for India's coronavirus crisis.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting